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Hypoxia of renal medulla is a key factor implicated in the
development of drug-induced renal failure. Drugs are known
to influence renal hemodynamics and, subsequently, affect
renal tissue oxygenation. Changes in renal oxygenation
can be assessed non-invasively in humans using blood
oxygenation level-dependent magnetic resonance imaging
(BOLD-MRI). This study was designed to test the acute effects
of administration of specific drugs in healthy human kidney
oxygenation using BOLD-MRI. Acute changes in renal tissue
oxygenation induced by the non-steroidal anti-inflammatory
drug indomethacin, the iodinated radio-contrast media
(RCM) iopromidum, and the calcineurin inhibitors
cyclosporine micro-emulsion (CsA-ME) and tracrolimus were
studied in 30 healthy volunteers. A modified Multi Echo Data
Image Combination sequence was used to acquire 12
T2*-weighted images. Four coronal slices were selected to
cover both kidneys. The mean R2* (1/T2*) values determined
in medulla and cortex showed no significant changes
induced by indomethacin and tacrolimus administration.
CsA-ME decreased medullary (P¼ 0.008) and cortical
(P¼ 0.004) R2* values 2 h after ingestion. Iopromidum caused
a significant increase in medullary R2* within the first 20 min
after injection (Po0.001), whereas no relevant changes were
observed in renal cortex. None of the measurements showed
left–right kidney differences. Significant differences in renal
medullary oxygenation were evidenced between female and
male subjects (P¼ 0.013). BOLD-MRI was efficient to show
effects of specific drugs in healthy renal tissue. Cyclosporine
increased renal medullary oxygenation 2 h after ingestion of
a single dose, whereas indomethacin and tacrolimus showed
no effect on renal oxygenation. Injection of iodinated RCM
decreased renal medullary oxygenation.
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Adequate renal perfusion and tissue oxygenation is critical
for the maintenance of normal renal function. Severe
impairment of renal hemodynamics leads to renal hypoxia
and failure.1 Several drugs currently used, like the non-
steroidal anti-inflammatory drug (NSAID) indomethacin, the
iodinated radio-contrast media (RCM), and the immuno-
suppressive drugs cyclosporine A (CsA) and tacrolimus, are
well-known agents influencing renal hemodynamics and thus
affecting renal tissue oxygenation by influencing renal
perfusion and/or oxygen consumption.2 Measurement of
renal tissue oxygenation in humans by means of blood oxygen
level-dependent (BOLD) magnetic resonance imaging (MRI)
offers a non-invasive tool to assess regional oxygenation of
tissue and, subsequently, to study the effect of specific drugs
on tissue oxygenation.3
BOLD-MRI is sensitive to disturbances of the local
magnetic field caused by variations in the oxygen level in
hemoglobin molecules, thus using deoxygenated hemoglobin
as an endogenous contrast agent. The resulting magnetic
susceptibility effect causes a loss of phase coherence, lead-
ing to signal attenuation on T2*-weighted MR images. The
ratio of oxyhemoglobin (diamagnetic) to deoxyhemoglobin
(paramagnetic) concentrations is proportional to the partial
pressure of oxygen (pO2) of blood, and blood pO2 is
supposed to be in balance with the surrounding tissue.
Therefore, BOLD signal estimated by transverse relaxation
rate R2* (1/T2*) can be considered as a sensitive indicator of
tissue pO2.
3,4
NSAIDs are widely used because of their efficacy and
excellent safety profile. However, these drugs have multiple
effects on kidney function. NSAID block the synthesis of
vasodilatory prostaglandins, which have an intermediatory
role in renal hemodynamics. The application of NSAID
shifts the balance between vasoconstrictors and vasodilators
towards vasoconstrictors and thus reduces renal perfusion
reversibly.1 In patients with pre-existing renal disease, these
drugs may worsen renal function.
Calcineurin inhibitors are the mainstay of immunosup-
pression in renal transplantation. CsA and tacrolimus are
currently the most widely used baseline immunosuppressants
for prevention of acute rejection following kidney transplant-
ation. However, their use is limited by acute and chronic
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toxicity. Acute nephrotoxicity of CsA is reversible and
partially caused by a decrease in renal blood flow related to
afferent arteriolar vasoconstriction.5 Tacrolimus nephrotoxic
effects seem identical or slightly less than those of CsA. But
tacrolimus does not show any vasocontrictory properties and
has apparently no hemodynamic effects in the kidney.5
Diagnostic and interventional procedures using iodinated
RCM are performed with increasing frequency. In parallel,
iodinated RCM nephropathy has become a frequent cause
of hospital-acquired acute renal failure.6,7 The overall
incidence of contrast-induced nephropathy is estimated to
be 0.6–2.3%.8 In high-risk patients undergoing angiographic
procedures or patients with pre-existing renal failure, the
incidence is higher: 14.5% after coronary intervention,9
16.8% in high-risk patients undergoing cardiac or peripheral
angiography,10 or even 40% in patients with severe pre-
existing renal failure.11 The mechanisms of iodinated RCM
nephropathy are not fully understood and a combination of
different mechanisms may be involved in the radio-contrast-
induced acute renal failure.6 A shift of the medullary oxygen
balance towards elevated hypoxia, induced by an imbalance
of vasodilator and vasoconstrictor factors, with a negative
effect on renal hemodynamics is believed to play a key role.
This reduction of medullary tissue oxygenation is caused by
alteration in medullary blood flow or enhanced oxygen
requirement. Liss et al.12 have measured medullary oxygena-
tion in rats after injection of RCM.12 Iopromide (low-
osmolal monomer) had the least effect of the contrast media
studied (ioxalgate and iotrolan). It is not known if such an
effect occurs also in humans.
BOLD-MRI offers the possibility to monitor intra-
renal oxygenation non-invasively in humans after drug
intake. The aim of this study was to analyze the acute effect
of selected drugs (indomethacin, cyclosporine microemul-
sion (CsA-ME), and tacrolimus) and iodinated RCM (iopro-
midum) on renal perfusion in healthy subjects by means of
BOLD-MRI measurements. Such measurements might ulti-
matively represent a new approch for a better understanding
of the effects of these drugs on kidney oxygenation, and
hence open novel possibilities for drug monitoring in
kidney transplantation and for prevention of RCM-induced
nephropathy.
RESULTS
Baseline R2* values ranged from 13.3 to 20.7 s
1 (mean
16.872.2 s1) for the medulla and from 9.7 to 13.1 s1
(mean 11.270.8 s1) for the cortex. Mean R2* values for the
subgroup gender yielded a significance for R2* values of the
cortex between female and male subjects (Table 1). The mean
coefficient of variation (inter-individual coefficient of varia-
tion) between volunteers was 13 and 7% in medulla and
cortex, respectively. The average intra-individual coefficient
of variation for the eight re-investigated subjects was 9% in
medulla and 5% in cortex.
Indomethacin administration did not induce significant
changes in renal R2* for the medulla or for the cortex
(Figure 1). Multiple analysis of variance (MANOVA) with
repeated measures showed a tendency to lower R2* values
with time (Table 2). No significant difference was found
between right and left kidney (Table 2).
Table 1 | R2* values
Number Gender Age R2* medulla R2* cortex
30 F+M 30.779.7 16.872.2 11.270.8
Range: 18–50
15 F 30.779.3 16.171.9 10.970.6a
Range: 20–49
15 M 30.6710.3 17.472.4 11.670.9a
Range: 18–50
F: female, M: male; age: average7s.d.; R2*: average7s.d.
aSignificant difference between gender (P=0.013).
Table 2 | P-values of MANOVA
Repeated measures Bonferroni baseline vs t
Location Time Pa t1 t2 t3 t4
Contrast agent Medulla o0.001* 0.890 0.432 0.002* o0.001* o0.001*
Cortex 0.45# 0.989 0.008* 0.501* 0.578 0.783
Indomethacin Medulla 0.096 0.605 0.287 0.148 0.855 0.136
Cortex 0.066 0.996 0.956 0.173 0.364 0.496
Cyclosporine Medulla 0.004* 0.771 0.014# 0.934
Cortex 0.004* 0.688 0.001* 0.018#
Tacrolimus Medulla 0.317 0.300 0.604 0.349
Cortex 0.226 0.983 0.315 0.533
MANOVA, multiple analysis of variance.
aP: right vs left; *Po0.01; #Po0.05.
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Figure 1 | Time-dependent effect of indomethacin (100 mg p.o.,
Indocids) on R2* value in renal cortex and medulla (mean7
s.e.m., n¼ 10, P¼NS).
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A significant reduction (P¼ 0.004) (MANOVA) in cortical
R2* values was observed 2 h after CsA-ME administration.
This effect was reversed 2 h later (Figure 2 and Table 2).
Repeated measures detected significant changes in the
medulla, and pairwise comparison between baseline and the
third point (t2) after 4 h showed a significant difference
(Table 2). No significant differences between right and left
kidney were found (Table 2).
No significant correlation was found between R2* value
and blood CsA concentration [cyclo] (medulla: R2*¼
0.0016[cyclo]þ 18.542, R2¼ 0.0643; cortex: R2*¼ 0.0001
[cyclo]þ 11.106, R2¼ 0.0028).
Tacrolimus had no significant effect on R2* values for
medulla or cortex (Figure 3). Neither right–left differences
(Table 2) nor significant correlations between R2* index and
blood tacrolimus concentrations [tacro] were observed
(Figure 3) (medulla: R2*¼0.005[tacro]þ 16.397, R2¼
0.0035; cortex: R2*¼ 0.0195[tacro]þ 10.324, R2¼ 0.1447).
Regression analysis between the difference of R2* values
(DR2*¼R2* (2 h after cyclosporine dosing)–R2* (at baseline))
and the blood concentrations of cyclosporine or tacrolimus
remained negative.
Iodinated RCM iopromidum produced an increase in
medullary R2* value 20 min after administration (Figure 4).
This effect was highly significant in the medulla when ana-
lyzed with MANOVA with repeated measures (Figure 5 and
Table 2). No relevant changes were observed in cortical R2*
index, but repeated measures showed a tendency for changes
with time in the cortex, mainly because of the first drop
(Bonferroni test; Table 2). No significant differences between
the right and left kidney were detected (Table 2).
Data obtained after placebo measurements showed no
statistically significant difference in the time course for the
repeated measures (MANOVA; Figure 6). There was also no
significant difference between right and left kidney.
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Figure 2 | Time-dependent effect of CsA-ME (6 mg/kg p.o.,
Sandimmun Neorals) on R2* value in renal cortex and medulla
(mean7s.e.m., n¼ 10, *Po0.002).
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Figure 3 | Time-dependent effect of tacrolimus (0.2 mg/kg p.o.,
Prografs) on R2* value in renal cortex and medulla (mean7
s.e.m., n¼ 10, P¼NS).
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Figure 4 | R2* color map (a) before and (b) 20 min after injection
of RCM iopromidum in a healthy volunteer. Arrows indicate zones
of medullary R2* increase after RCM administration.
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Figure 5 | Time-dependent effect of iodinated RCM iopromidum
(2 ml/kg intravenous (bolus) (Ultravist300s) on R2* value in renal
cortex and medulla (mean7s.e.m., n¼ 10, *Po0.001).
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Figure 6 | Time-dependent effect of placebo measurements
(i.e. without medication) (mean7s.e.m., n¼ 8, P¼NS).
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DISCUSSION
BOLD-MRI is the only technique currently available that
allows non-invasive estimation of oxygen content in human
kidney and offers the ability to perform measurements
dynamically.3 Beside microscopic field heterogeneity due
to deoxy-hemoglobin, R2* values are influenced by other
factors including macroscopic field homogeneity, vascular
volume, and hematocrit. In addition, a nonlinear relationship
between R2* and pO2 makes a quantitative interpretation
of BOLD data in terms of mm Hg (pO2) difficult.
13 However,
as macroscopic field homogeneity and spin–spin relaxation
process most probably remain constant during the study
presented here, changes in BOLD-MRI signal intensity
represented by R2* values may reflect the changes in pO2
of tissues and, therefore, allow to assess the effect of drugs
on renal tissue oxygenation.
The mean R2* values in medulla (16.8 s
1) and cortex
(11.2 s1) are in the range of those described in the literature
for baseline results (i.e. without stimulation) in normal
subjects.3,14–16 Li et al.16 described R2* values between 15.2
and 25.3 s1 in baseline medulla and between 10.5 and
16.6 s1 in baseline cortex. In our previous study, the R2*
values ranged from 15 to 19 s1 in the medulla and 11 to
12.5 s1 in the cortex.17 Prasad et al.3 obtained mean R2*
indices between 19 and 20.5 s1 in the medulla and between
12.3 and 13.1 s1 in the cortex. Epstein et al.14,15 found mean
R2* values of 17.4 s
1 for the medulla and 12.9 s1 for the
cortex and 17 s1 for the medulla and 12.6 for the cortex in
the younger group. The results obtained in the present
study are slightly lower than the mean values reported.
This difference is partly explained by the study protocol.
For logistical reasons, the BOLD-MRI measurements were
not performed at the same time of the day in all the volun-
teers, the subjects were normally hydrated, but not submitted
to an acute water load. As expected, R2* values are consis-
tently higher in medulla than in cortex, indicating that renal
medulla is more hypoxic than cortex in normal subjects.3
A significant difference in the cortical R2* values between
female and male subjects was observed (Table 1). This novel
finding indicates that the renal medulla of female subjects
contains a higher tissue oxygenation content when compared
to male subjects. The mechanism and the possible patho-
physiological implication are unknown. One might speculate
whether estrogens known to modulate renin angiotensin or
nitric oxide formation in female subjects might account for
the observed gender difference.18,19
Hypoxic injury to renal medulla is one of the mechanisms
that initiates the phenomenon of acute renal failure.1 There-
fore, it seems important to know whether specific drugs used
in clinical practice can affect renal medullary oxygenation in
humans and to which extent. Applying BOLD-MRI on eight
subjects after administration of placebo medication allowed
to establish unambiguously that the measured time course of
the R2* values after drug administration was an effect of the
medication and no random finding. The acute drug exposure
revealed xenobiotic-specific results in healthy volunteers.
Indomethacin, given as a single oral dose, did not change
renal tissue R2* (Figure 1). This is a practically relevant
observation, indicating that a single dose of indomethacin as
prescribed routinely does not influence renal cortical or
medullary tissue oxygenation in humans. Nevertheless, some
caution must be taken, as patients might react differently and
repeated dosing of indomethacin for several days might be
more deleterious for kidney oxygenation. In addition, dose
and hydration status might be of pivotal relevance, as in rats a
decrease in cortical pO2 and a reduction of 57% in medullary
oxygenation was observed after a higher dose of indometha-
cin (10 mg/kg body weight (bw)) given intravenously in salt-
depleted rats.20 Similar observations were reported by Prasad
et al.21 and by Agmon et al.,22 using intravenous injection of
indomethacin in rats. In addition, an effect of indomethacin
might have been missed in this study because of the relatively
short observation time. Nevertheless, the present results
indicate that a single dose of indomethacin may have
minimal effect on human kidney oxygenation. This observa-
tion is in line with other studies in humans. Sturrock et al.23
and Olsen et al.24 found neither a change in renal sodium and
water handling nor in glomerular filtration rate, effective renal
plasma flow, and renal vascular resistance after 2 100 mg
indomethacin administration in healthy male subjects.
Nephrotoxicity, one of the side effects of calcineurin
inhibitors, CsA and tacrolimus, contributes to long-term
renal graft failure and cardiovascular morbidity in organ
recipients.25 One possible mechanism for this nephrotoxicity
might be a decrease of tissue oxygenation by influencing
renal hemodynamics. Indeed, Klein et al.5 presented evidence
that cyclosporine but not tacrolimus given for 2 weeks
decreased renal glomerular filtration rate and effective renal
plasma flow in healthy volunteers. The observation of the
absence of an effect of tacrolimus in the present investigation
is in line with the latter study. However, the reduced renal
perfusion, with a decline in the glomerular filtration rate
observed by Klein et al.,5 appears to be in contradiction with
the increased oxygenation after cyclosporine in our volun-
teers. The difference between the two studies might be best
explained by the much higher total doses of CsA-ME given by
Klein et al.5 (single dose of 6 mg/kg bw vs 10 mg/kg bw for 2
weeks).5 Note that contradiction might only be apparent as
the medullary oxygen content depends not only on the
perfusion but in addition on active tubular sodium transport,
that is, tissue oxygen consumption. If this transport is
reduced out of proportion relative to the reduced perfusion,
then the medullary oxygen content might increase, despite a
decreased perfusion following cyclosporine dosing, a hypo-
thesis that deserves further consideration. In contrast to
CsA, tacrolimus showed no effect on medullary oxygena-
tion, suggesting different influence on intrarenal oxygen
distribution. Whether this is important in the pathogenesis
of calcineurin inhibitor-induced nephrotoxicity remains an
open question.
The iodinated RCM iopromidum produces a rapid and
sustained increase in medullary R2*, indicating a severe
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decrease (22 and 28%) in renal medullary oxygenation 20
and 35 min after injection, respectively (Figure 5). To
illustrate this effect, R2* color maps are shown in Figure 4.
Similar observations have been made in animal studies by
Liss et al.,12,26 who found in rats injected a high dose
of iopromide (2.5 times the dose used in this study), a
reduction of pO2 of 40% in the medulla and a slight, yet
not significant decrease in the cortex. Prasad et al.21 reported
no change in medullary R2* values in animals during the first
15 min following the administration of RCM iothalamate.
This lack of a change in medullary R2* values directly after
intravenous injection of iothalamate might be a consequence
of the short observation period of 15 min.21 In the present
study in human volunteers (Figure 4), medullary R2* values
were increased as early as 20 min after RCM administration
and continued to be elevated during the 45 min of
observation time. The marked and sustained reduction in
medullary pO2 seen after intravenous injection of iopromide
has important clinical consequences. Prevention of RCM-
induced medullary hypoxia by drug therapy and/or aggres-
sive volume substitution might reduce the risk of acute renal
failure after RCM administration.
Conclusion and outlook
The present study allowed to assess the acute renal effects
of several drugs in healthy human volunteers. Cyclosporine
(CsA-ME) increased renal medullary oxygenation 2 h after
ingestion of a single dose, whereas indomethacin and
tacrolimus had no effect on renal oxygenation. Injection of
iodinated RCM decreased renal medullary oxygenation in
healthy humans. BOLD-MRI is a non-invasive tool to detect
early functional changes, owing to changes in tissue content
of oxygen, and may therefore be of value to develop new
strategies to reduce medullary hypoxia attributable to drugs
or RCM. The present investigation was performed in healthy
volunteers without apparent risk factors for nephrotoxicity of
the xenobiotics given. It is reasonable to assume that the
susceptibility of the kidney to these xenobiotics in disease
states when the autocrine and paracrine defense mechanisms
are not operative in order to preserve medullary integrity
and function is completely different from that in healthy
volunteers.1,27,28 As a corollary, the observations made in the
present study in healthy subjects are not a priori completely
predictive for observations in patients. Thus, future studies
should focus on the effect of the nephrotoxic agents
investigated in the present study in subjects with well-defined
pathological entities.
MATERIALS AND METHODS
Study protocol
The study was designed as a prospective, open study. Approval of
the institutional Ethical Committee was obtained and all subjects
gave informed consent before entering the study.
Fifteen female and 15 male healthy volunteers at an age of
18–50 years (mean age of 30.779.7 years) and body mass index
o29 kg/m2 have been included in the study. One volunteer
participated in all the four studies and nine in two studies. Physical
examination including body height and weight, blood pressure and
heart rate, serum creatinine, and urine tests were completed in all
patients. For volunteers who received RCM, a normal thyroid
stimulating hormone concentration was required before entering the
study. Exclusion criteria were impaired renal function (serum
creatinine 4100 mM/l for men and 490 mM/l for women), predispo-
sition to atopia (asthma, eczema, urticaria, and allergic conjuncti-
vitis), history of allergy to RCM or iodine allergy, thyroid disease,
pregnancy, medical therapy (diuretics, angiotensin-converting
enzyme inhibitors, CsA or CsA-ME, NSAID), or infective disease
during 2 weeks before the study or contra-indication for MR
examination.
The volunteers were allocated to four groups (Table 3):
indomethacin, CsA-ME and tacrolimus, and iopromidum, an
iodinated RCM. The dosage of medication and RCM corresponds
to the amount used in humans for treatment or routine radiological
examinations, in particular abdominal CT. The volunteers received
either indomethacin 100 mg per os (Merck Sharp & Dohme-Chibret
Inc., Whitehouse Station, NJ, USA), CsA-ME 6 mg/kg bw p.o.
(Novartis Pharma Ltd, Basel, Switzerland), tacrolimus 0.2 mg/kg bw
p.o. (Fujisawa Ireland Limited, Killorglin Co., Kerry, Ireland), or
iopromidum 2 ml/kg bw intravenous (Schering, Berlin, Germany)
(Table 3).
Steady-state BOLD-MRI measurements were performed on all
the volunteers before administration of the drugs. The subsequent
procedure depending on the studied drug is outlined in Table 3.
Indomethacin was orally applied while the volunteer was lying in the
MR scanner. RCM was injected (Medrad Spectris MRI Injector,
Medrad Inc., Indianola, PA, USA) at a flow rate of 1.5 ml/s. For both
drugs, MR measurements were repeated 5, 20, 35, and 45 min after
Table 3 | Study design and characteristics of volunteers
Drugs Indomethacin Radiocontrast iopromidum
Cyclosporine
microemulsion Tacrolimus
Trade name Indocids Ultravist300s Sandimmun Neorals Prografs
Dosage 100 mg p.o. 2 ml/kg intravenous (bolus) 6 mg/kg p.o. 0.2 mg/kg p.o.
Measurements 0, 5, 20, 35, and 45 min after
drug administration
0, 5, 20, 35, and 45 min after
drug administration
0, 120, and 240 min after
drug administration
0, 120, and 240 min after
drug administration
Blood samples None 0 min: sCreat, TSH 120 min: sCreat, Cyclo; 120 min: sCreat, Tacro;
240 min: sCreat, Cyclo 240 min: sCreat, Tacro
Age (years) 30.7710.7 30.2710.3 29.2711.3 31.9711.7
Gender (F/M) 4/6 3/7 4/6 7/3
Number n=10 n=10 n=10 n=10
Cyclo, cyclosporine concentration; F, female; M, male; p.o., per os; sCreat, serum creatinine concentration; Tacro, tacrolimus concentration; TSH, thyroid stimulation hormone.
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administration (Table 3). CsA-ME and tacrolimus were orally taken
by the volunteers outside the MR scanner, and BOLD measurements
were repeated 120 and 240 min after ingesting the drugs. Serum
creatinine, CsA, or tacrolimus blood levels were determined imme-
diately after the MR examination.
Eight of the 30 volunteers (randomly selected, three women,
five men) underwent a repeated BOLD-MRI study using a placebo
(a glass of water or NaCl injection) after 3–7 months.
In this study, the subjects were not asked to abstain from food
and water overnight. However, we assume that variations in the
overnight water intake would be negligible and that all the subjects
were well hydrated at the time of acquisition.
Laboratory methods
Urinary glucose, protein, or hemoglobin was analyzed by stix
analysis (Multistixs, Bayer, USA). Serum creatinine was measured
by the enzymatic plus-Method on a Hitachi 917 analyzer (Roche,
Rotkreuz, Switzerland). Serum thyroid stimulating hormone and
CsA levels were assessed by the Abbott-FPIA-Method (Abbott AG,
Baar, Switzerland) and tacrolimus was measured by the Abbott-
MEIA-Method (Abbott AG, Baar, Switzerland).
MR measurements
All MR measurements were carried out on a syngo-based 1.5 T
whole-body MR system (SONATA, Siemens Medical Systems,
Erlangen, Germany) using the body coil for transmission and a
phased array surface coil for reception. For morphological evalu-
ation of the kidneys, coronal T2-weighted fat suppressed Half-
fourier Acquisition Single-shot Turbo spin-Echo images were
acquired (repetition time (TR) 1010 ms, echo time (TE) 81 ms, flip
angle 1501, field of view (FOV) 400 400 mm2, voxel size 1.1
0.8 5.0 mm3), followed by T1-weighted Fast Low Angle SHot
(FLASH) gradient-echo sequence images in axial and coronal
orientation (TR 65 ms, TE 4.76 ms, flip angle 701, FOV 400
400 mm2, voxel size 1.1 0.8 5.0 mm3). Four slices with good
cortico-medullary differentiation were then selected for functional
evaluation with BOLD-MRI.
Twelve T2*-weighted images were recorded within a single
breath-hold of 17 s using a modified Multi Echo Data Image
Combination sequence17 with the following parameters: TR 65 ms,
TE 6–52.31 ms (inter-echo spacing 4.21 ms), flip angle 301, FOV
400 400 mm2, voxel size 1.6 1.6 5 mm3, bandwidth 325 Hz/
pixel, matrix 256 256 with an interpolation in both directions to
512 512.
Data were transferred to a standard personal computer. R2* maps
were calculated voxel by voxel, using a home-built IDL program
(Interactive Data Language, RSI, Boulder, CO, USA). As the fit of
more than 250 000 exponential functions per image was too time
consuming, the following function (equation (1)) was minimized
instead:29
Xn
i¼1
yiðlnðyiÞ  abxiÞ2 ð1Þ
The weighting of the function by yi compensates for the logarithmic
transformation of the Rician noise that occurs with the linearization
of the exponential function. As the longest TE used in this
experiment was 52.31 ms with T2* between 50 and 100 ms, the signal
amplitudes were well above noise level and, therefore, Rician noise
approached a Gaussian distribution. Regions of interest were
selected in the medulla and the cortex, and a mean value of R2*
index was estimated. Because of the heterogeneity of contrast
changes within cortex and medulla, the regions of interest were
chosen in a homogenous part of the cortex or the medulla.3
Statistical significance of the results was analyzed using
MANOVA for repeated measures (time) and three variables
(volunteer, medulla/cortex, and left/right kidney) with Bonferroni
adjustment for multiple comparison (SPSS11.0 for Windows,
Chicago, IL, USA). For gender differences, a two-sided unpaired
Student’s t-test was applied (SYSTAT 10.0 for Windows, Systat
Software Inc., Richmond, CA, USA). The intra- and inter-individual
coefficient of variation represents the s.d. divided by the mean
R2* value for different measurements and/or different subjects.
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